Monday, June 8, 2026
🇺🇸 FDA

pharma

Biolitec Pharma

Biolitec Pharma Ltd

Biolitec Pharma is a pharma organization headquartered in GB. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sourc

GB HQ
Public company Type
Programs 0 Drugs 0 Patents 25
Company details
Status
Public
HQ
GB
Programs
0
Drugs
0
Patents
25
Patents News & analysis
Intelligence · Patents

Biolitec Pharma patents

25 pharmaceutical patents indexed for Biolitec Pharma. 4 expire within 24 months.

Biolitec Pharma has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

25 patents

Patent portfolio

  1. BR PI0714667

    conjugado molecular e respectivo uso

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. MX 2013000877

    APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.

    Expires Tue Jun 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 2013041307

    APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT

    Expires Wed Feb 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2013015774

    DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE

    Expires Wed Jan 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. BR PI0614453

    método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 2012263625

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

    Expires Wed Oct 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 2012259187

    DYNAMIC COLORECTAL PDT APPLICATION

    Expires Wed Oct 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 2011206613

    METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT

    Expires Wed Aug 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 2011178580

    ENHANCED ANTI-MICROBIAL PDT

    Expires Wed Jul 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. CA 2784005

    SYSTEMES DE VEHICULES NANOPARTICULAIRES A BASE DE POLY (ACIDE DL-LACTIQUE - CO - GLYCOLIQUE) (PLGA) POUR THERAPIE PHOTODYNAMIQUE (PDT)

    Expires Wed Jun 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 2011142948

    Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy

    Expires Wed Jun 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 2010273803

    Oral Formulations for Tetrapyrrole Derivatives

    Expires Wed Oct 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 2010247626

    PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION

    Expires Wed Sep 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. EP 2222277

    PEGYLIERTE LIPOSOMALE FORMULIERUNGEN ZUR PHOTODYNAMISCHEN BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN

    Expires Tue Aug 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 2009326434

    Anti-Microbial Photodynamic Therapy

    Expires Wed Dec 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 2009171262

    Method and Mixture for In Vivo Photochemical Cross-Linking of Collagen

    Expires Wed Jun 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 2009169611

    Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications

    Expires Wed Jun 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 2009062719

    Enhanced PhotoDynamic Therapy with Immune System Assist

    Expires Wed Feb 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. EP 1959855

    BEHANDLUNG VON BENIGNER PROSTATAHYPERPLASIE MIT EINEM FOTOSENSIBILISATOR UND LASERABLATION

    Expires Tue Aug 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 2007166369

    Photodynamic cosmetic procedure and healing method

    Expires Wed Jul 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. EP 1786431

    VERBESSERTE PHOTOSENSITIZERFORMULIERUNGEN UND DEREN VERWENDUNG

    Expires Tue May 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. BR PI0414331

    método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica

    Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 2006127471

    Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy

    Expires Wed Jun 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. EP 1660041

    NICHTPOLARE PHOTOSENSIBILISATOR-FORMULIERUNGEN FÜR DIE PHOTODYNAMISCHE THERAPIE

    Expires Tue May 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 2005215524

    Methods and compositions for improving photodynamic therapy through administration of lipids

    Expires Wed Sep 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Biolitec Pharma have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Biolitec Pharma patents expire?

4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.